ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,457Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 288

$705K Total Retail Price of All Prescriptions

Rank: 25 out of 288

571 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 571 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 571 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 15,412 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 965 887 1 2
SIMVASTATIN 623 584 2 1
OMEPRAZOLE 560 525 3 3
FUROSEMIDE 481 470 4 5
HYDROCODONE-ACETAMINOPHEN 472 446 S3 5 7
AMLODIPINE BESYLATE 458 442 6 6
POTASSIUM CHLORIDE 382 375 7 11
SERTRALINE HCL 368 351 8 25
LISINOPRIL 336 321 9 4
ATENOLOL 312 293 10 10
CITALOPRAM HBR 273 241 11 18
HYDROCHLOROTHIAZIDE 269 257 12 13
LOSARTAN POTASSIUM 269 248 12 16
METOPROLOL TARTRATE 239 215 14 8
PRAVASTATIN SODIUM 226 223 15 21
ZOLPIDEM TARTRATE 206 167 16 22
ATORVASTATIN CALCIUM 191 176 17 14
PANTOPRAZOLE SODIUM 189 153 18 42
POLYETHYLENE GLYCOL 3350 186 181 19 38
METFORMIN HCL 180 175 20 12
WARFARIN SODIUM 177 157 21 9
MIRTAZAPINE 174 174 22 60
CARVEDILOL 172 172 23 27
GABAPENTIN 168 168 24 17
ALENDRONATE SODIUM 163 159 25 20
IPRATROPIUM-ALBUTEROL 160 160 26 99
DIOVAN 159 136 27 53
JANTOVEN 159 159 27 146
METOPROLOL SUCCINATE 152 152 29 15
DONEPEZIL HCL 146 146 30 29
TRAMADOL HCL 145 145 31 19
TRIAMTERENE-HCTZ 131 131 32 28
PREDNISONE 129 127 33 30
LOVASTATIN 127 127 34 46
ALLOPURINOL 124 124 35 23
NAMENDA 123 123 36 39
CRESTOR 120 120 37 26
CLONIDINE HCL 111 103 38 70
FLUTICASONE PROPIONATE 109 102 39 41
BENAZEPRIL HCL 108 100 40 52
VESICARE 101 88 41 129
AMITRIPTYLINE HCL 101 90 R 41 65
ESCITALOPRAM OXALATE 98 96 43 87
FAMOTIDINE 98 98 43 68
LIDODERM 98 98 43 157
ISOSORBIDE MONONITRATE ER 97 97 46 35
TRIAMCINOLONE ACETONIDE 96 95 47 139
DETROL LA 96 94 47 162
CARBIDOPA-LEVODOPA 93 79 49 72
FENTANYL 93 93 S2 49 57
DILTIAZEM ER 91 88 51 102
CEPHALEXIN 79 76 52 83
OXYBUTYNIN CHLORIDE ER 79 79 52 116
MELOXICAM 78 68 54 44
VERAPAMIL ER 72 72 55 97
VENLAFAXINE HCL ER 68 58 56 94
GLIPIZIDE 68 57 56 56
CELEBREX 66 52 58 84
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 64 59 34
LEVOFLOXACIN 65 64 59 80
NEXIUM 64 47 61 43
METHOCARBAMOL 63 36 R 62 232
PAROXETINE HCL 60 59 63 54
DILTIAZEM 24HR CD 59 59 64 75
AZITHROMYCIN 59 54 64 49
CYMBALTA 57 54 66 67
LANTUS SOLOSTAR 57 47 66 81
BUMETANIDE 57 55 66 105
ADVAIR DISKUS 57 57 66 50
METHYLPREDNISOLONE 57 55 66 197
CIPROFLOXACIN HCL 55 53 71 62
QUETIAPINE FUMARATE 55 55 71 92
PREMARIN 54 53 R 73 143
NYSTOP 53 53 74 220
SYNTHROID 53 52 74 63
TRAZODONE HCL 53 39 74 37
ROPINIROLE HCL 51 46 77 74
LABETALOL HCL 51 51 77 147
DIGOXIN 50 47 79 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.